Clinical use and applications of histone deacetylase inhibitors in multiple myeloma

The incorporation of various novel therapies has resulted in a significant survival benefit in newly diagnosed and relapsed patients with multiple myeloma (MM) over the past decade. Despite these advances, resistance to therapy leads to eventual relapse and fatal outcomes in the vast majority of pat...

Descripción completa

Detalles Bibliográficos
Autores principales: Tandon, Nidhi, Ramakrishnan, Vijay, Kumar, Shaji K
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2016
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4866749/
https://www.ncbi.nlm.nih.gov/pubmed/27226735
http://dx.doi.org/10.2147/CPAA.S94021

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4866749/
https://www.ncbi.nlm.nih.gov/pubmed/27226735
http://dx.doi.org/10.2147/CPAA.S94021

Ejemplares similares